FDA clears Intuitive da Vinci 5
Intuitive received FDA 510(k) clearance for da Vinci 5, its fifth-generation multiport robotic surgical system.
Evidence notes
- The system introduced optional Force Feedback instruments and a redesigned console.
- Intuitive described more than 150 system enhancements and expanded computing capacity.
- Initial U.S. availability was limited to selected customers before broader commercial introduction.
Company context
Intuitive develops robotic-assisted surgical systems, including the da Vinci surgical platform and Ion endoluminal system.